Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: Effects on inflammatory response during coronary artery surgery

British Journal of Anaesthesia

Volumn 95, Issue 4, 2005, Pages 448-457

  Visser, L ^a   Zuurbier, C J ^a   Hoek, F J ^a   Opmeer, B C ^a   de Jonge, E ^a   de Mol, B A J M ^a   van Wezel, H B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Complications, systemic inflammatory response syndrome; Metabolism, glucose; Metabolism, hyperglycaemia; Metabolism, insulin; Surgery, cardiovascular

Indexed keywords

AMYLOID A PROTEIN; APROTININ; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CHLORIDE; GLUCOSE; HEPARIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MANNITOL; MORPHINE; NEUTRAL INSULIN; PANCURONIUM BROMIDE; POLYGELINE; POTASSIUM; PROCAINE; PROPOFOL; PROTAMINE; ST THOMAS HOSPITAL SOLUTION; SUFENTANIL CITRATE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DRUG DOSE REGIMEN; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HEART LEFT VENTRICLE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 26444588755     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei220     Document Type: Article

References (47)

1. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80: 3A-10A
2. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67
3. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 104: 1497-1502
4. Opie LH, Bruyneel K, Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation 1975; 52: 49-57
5. Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Rackley CE. Glucose-insulin-potassium, free fatty acids and acute myocardial infarction in man. Circulation 1976; 53 (Suppl): 1207-9
6. Dalby AJ, Bricknell OL, Opie LH. Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res 1981; 15 588-98
7. Coleman GM, Gradinac S, Taegtmeyer H, Sweeney M, Frazier OH. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation 1989; 80: 191-6
8. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 1995; 60: 411-16
9. Svedjeholm R, Hakanson E, Vanhanen I. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery. Ann Thorac Surg 1995; 59 (Suppl): S15-22
10. Diaz R, Paolasso EA, Piegas LS et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227-34
11. Jeschke MG, Einspanier R, Klein D, Jauch KW. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002; 8: 443-50
12. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145: 4084-93
13. Chaudhuri A, Janicke D, Wilson MF et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004; 109: 849-54
14. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52
15. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999; 89: 1091-5
16. Marfella R, Siniscalchi M, Esposito K et al. Effects of stress hyperglycemia on acute myocardial infarction: Role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26: 3129-35
17. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-72
18. Svedjeholm R, Huljebrant I, Hakanson E, Vanhanen I. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg 1995; 59: S23-30
19. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg 2004; 99 319-24
20. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000; 70: 145-50
21. Woods AA, Taegtmeyer H. Reversal of glucose-insulin-potassium-induced hyperglycemia by aggressive insulin treatment in postoperative heart failure. An observational study. Cardiology 2004; 102: 82-8
22. Mehta SR, Yusuf S, Diaz R et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 2005 26; 293: 437-46
23. Van den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-66
24. Mazuski JE, Bailey JA, Shapiro MJ. Intensive insulin therapy in critically ill patients. N Engl J Med 2002; 346: 1586-8
25. Ostenson CG, Cattaneo AG, Doxey JC, Efendic S. Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats. Am J Physiol 1989; 257: E439-43
26. McPherson BC, Yao Z. Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 2001; 103: 290-5
27. Doyle ME, Egan JM. Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 2003; 55: 105-31
28. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376-82
29. + channel-independent mechanism is involved in glucose-excited neurons of mouse arcuate nucleus. Diabetes 2004; 53: 2767-75
30. Wang R, Liu X, Hentges ST et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004; 53: 1959-65
31. Aouifi A, Piriou V, Blanc P et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 1999; 83: 602-7
32. Vanek T, Brucek P, Straka Z, Klepetar J, Maly M. Development of C-reactive protein and fibronectin levels in coronary surgery patients: a comparison of on-pump, off-pump sternotomy and off-pump left anterior small thoracotomy groups. Jpn Heart J 2002; 43: 211-18
33. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-8
34. Roth-Isigkeit A, Schwarzenberger J, Borstel T et al. Perioperative cytokine release during coronary artery bypass grafting in patients of different ages. Clin Exp Immunol 1998; 114: 26-32
35. Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-I beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol 1999; 118: 242-6
36. Roth-Isigkeit A, Hasselbach L, Ocklitz E et al. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin Exp Immunol 2001; 125: 80-8
37. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265: 501-23
38. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-12
39. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-86
40. Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992; 12: 1789-97
41. Seshadri V, Fox PL, Mukhopadhyay CK. Dual role of insulin in transcriptional regulation of the acute phase reactant ceruloplasmin. J Biol Chem 2002; 277: 27903-11
42. Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. C-reactive protein in acute myocardial infarction: Association with heart failure. Am Heart J 2003; 145: 1094-1101
43. Shainkin-Kestenbaum R, Winikoff Y, Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol 1986; 39: 635-7
44. Ueda S, Ikeda U, Yamamoto K et al. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996; 131: 857-60
45. Anzai T, Yoshikawa T, Shiraki H et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997; 96: 778-84
46. Bisoendial RJ, Kastelein JP, Levels JHM et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005; 96: 714-16
47. Rinder CS, Fontes M, Mathew JP et al. Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. Ann Thorac Surg 2003; 75: 899-905